01 Licensing-first partnering
U.S.–China life-science collaboration is structured through licensing and service agreements, reviewed by counsel in both countries.
Clear rules for working across the United States and China.
U.S.–China life-science collaboration is structured through licensing and service agreements, reviewed by counsel in both countries.
Patient-level data remain in the country where they were collected. We share methods and models, never personal data.
Partners and suppliers are screened against the rules that apply in each country.
Health programs are measured against outcomes agreed in advance, and medical services are delivered only with licensed partners.